LENZ Lenz Therapeutics, Inc.

Fundamentals / CIK 0001815776 / USD

Lenz Therapeutics, Inc. reported $12.36M in revenue and a net loss of $140.3M for the trailing twelve months ended September 30, 2026 (down 72.9% year over year), with a 82.0% gross margin and a -1211.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LENZ in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$29.48M$14.74M$0-$96.11MFY 2020 Net Income: -$68.37M2020FY 2021 Net Income: -$70.76M2021FY 2022 Net Income: -$101.1M2022FY 2023 Net Income: -$69.97M2023FY 2024 Revenue: $0FY 2024 Net Income: -$49.77M2024FY 2025 Revenue: $19.09MFY 2025 Net Income: -$82.13M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $19.09M $0 -- -- -- --
Cost of Revenue $418K $0 -- -- -- --
Gross Profit $18.67M $0 -- -- -- --
Research & Development $18.67M $29.80M $59.50M $72.79M $37.93M $9.12M
Selling, General & Admin $91.14M $28.81M $12.93M -- -- --
Total Operating Expenses -- $58.61M $72.43M $105.6M $60.44M $13.50M
Operating Income -$91.14M -$58.61M -$72.43M -$105.6M -$60.44M -$13.50M
EBITDA -$90.85M -$58.55M -$72.41M -$103.3M -$59.71M -$13.38M
Interest Income $9.76M $8.55M $2.19M -- -- --
Income Before Tax -$81.62M -$49.77M -$70.15M -- -- --
Income Tax Expense $502K $1.0K -$179K $0 $0 $0
Net Income -$82.13M -$49.77M -$69.97M -$101.1M -$70.76M -$68.37M
Basic EPS -$2.85 -$2.34 -$35.71 -$1.84 -$2.45 -$29.93
Diluted EPS -$2.85 -$2.34 -$35.71 -$1.84 -$2.45 -$29.93
Basic Shares Outstanding 28.8M 21.3M 2.0M 54.9M 28.9M 2.3M
Diluted Shares Outstanding 28.8M 21.3M 2.0M 54.9M 28.9M 2.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $3.38M $5.49M $1.90M $1.59M $12.50M $5.00M $0 --
Cost of Revenue $454K $280K $1.08M $418K $0 $0 $0 --
Gross Profit $2.93M $5.21M $825K $1.17M $12.50M $5.00M $0 --
Research & Development $0 $0 $0 $0 $3.79M $9.06M $5.82M $5.87M
Selling, General & Admin $35.85M $39.38M $44.96M $39.63M $27.60M $12.80M $11.11M $9.36M
Total Operating Expenses -- -- -- -- $31.39M $21.86M $16.93M $15.22M
Operating Income -$32.92M -$34.17M -$44.13M -$38.46M -$18.89M -$16.86M -$16.93M -$15.22M
EBITDA -$32.81M -$34.06M -$44.02M -$38.36M -$18.76M -$16.84M -$16.89M -$15.20M
Interest Income $1.99M $2.27M $2.64M $2.99M $2.20M $2.25M $2.32M $2.57M
Income Before Tax -$30.97M -$31.91M -- -- -$16.70M -$14.41M -- --
Income Tax Expense $0 $3.0K -- -- $0 $500K -- --
Net Income -$30.97M -$31.92M -$41.49M -$35.90M -$16.70M -$14.91M -$14.62M -$12.65M
Basic EPS -$0.99 -$1.02 -$1.32 -- -$0.59 -$0.53 -$0.53 --
Diluted EPS -$0.99 -$1.02 -$1.32 -- -$0.59 -$0.53 -$0.53 --
Basic Shares Outstanding 31.4M 31.4M 31.4M -- 28.5M 28.1M 27.5M --
Diluted Shares Outstanding 31.4M 31.4M 31.4M -- 28.5M 28.1M 27.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $25.18M $20.16M $35.14M $47.73M $377.0M $19.78M
Short-Term Investments -- -- $30.65M $220.5M $0 --
Cash & Short-Term Investments $292.3M $209.1M $184.3M $283.6M $377.0M $19.78M
Accounts Receivable, Net $329K $0 -- -- -- --
Inventory $2.94M $0 -- -- -- --
Total Current Assets $301.4M $211.9M $67.24M $275.4M $381.7M $21.10M
Property, Plant & Equipment, Net $1.19M $651K $54K $22.63M $6.51M $1.46M
Long-Term Investments -- -- $0 $15.32M $0 --
Other Non-Current Assets $2.54M $1.40M $21K $1.29M $454K --
Total Non-Current Assets $4.46M $3.39M $3.13M $46.54M $20.25M $1.46M
Total Assets $305.9M $215.3M $70.38M $321.9M $402.0M $22.56M
Accounts Payable $4.17M $4.26M $5.71M $2.61M $2.45M $630K
Deferred Revenue (Current) $0 -- -- -- -- --
Total Current Liabilities $21.19M $10.41M $18.51M $13.04M $12.14M $32.05M
Other Non-Current Liabilities -- $0 $121K $10.82M $0 $316K
Total Non-Current Liabilities $350K $814K $1.18M $12.57M $5.79M $316K
Total Liabilities $21.54M $11.22M $19.70M $25.61M $17.94M $32.36M
Total Debt (incl. Leases) $815K $1.31M $362K $5.79M $11.28M --
Common Stock $1.0K $1.0K $10K $1.0K $1.0K --
Retained Earnings -$227.1M -$145.0M -$95.25M -$242.4M -$141.4M -$70.59M
Accumulated Other Comp. Income $242K $196K $6.0K -$1.05M $0 --
Total Stockholders' Equity $284.3M $204.1M -$92.71M -$24.17M $384.1M -$65.41M
Total Equity $284.3M $204.1M -$92.71M -$24.17M $384.1M -$65.41M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $30.55M $24.21M $24.77M $25.18M $25.40M $37.61M $23.04M $20.16M
Cash & Short-Term Investments $197.3M $220.0M $258.4M $292.3M $202.2M $209.6M $194.1M $209.1M
Accounts Receivable, Net $913K $442K $343K $329K -- -- -- $0
Inventory $4.76M $4.12M $3.50M $2.94M $949K -- -- $0
Total Current Assets $206.9M $233.3M $268.4M $301.4M $207.0M $213.6M $197.9M $211.9M
Property, Plant & Equipment, Net $640K $1.00M $1.10M $1.19M $1.26M $1.17M $926K $651K
Other Non-Current Assets $1.79M $1.79M $2.45M $2.54M $1.60M $1.60M $1.40M $1.40M
Total Non-Current Assets $2.85M $3.31M $4.17M $4.46M $3.71M $3.73M $3.39M $3.39M
Total Assets $209.7M $236.6M $272.5M $305.9M $210.7M $217.3M $201.3M $215.3M
Accounts Payable $5.52M $6.65M $10.93M $4.17M $4.32M $2.85M $3.66M $4.26M
Deferred Revenue (Current) -- $785K -- $0 -- -- -- --
Total Current Liabilities $17.75M $17.21M $25.81M $21.19M $16.32M $10.40M $8.57M $10.41M
Other Non-Current Liabilities -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $0 $122K $237K $350K $461K $569K $673K $814K
Total Liabilities $17.75M $17.33M $26.04M $21.54M $16.78M $10.97M $9.24M $11.22M
Total Debt (incl. Leases) $460K $569K $673K $815K $954K $1.05M $1.18M $1.31M
Common Stock $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K $1.0K
Retained Earnings -$331.5M -$300.5M -$268.6M -$227.1M -$191.2M -$174.5M -$159.6M -$145.0M
Accumulated Other Comp. Income -$1.06M -$629K -$450K $242K $227K $38K $123K $196K
Total Stockholders' Equity $192.0M $219.3M $246.5M $284.3M $193.9M $206.4M $192.0M $204.1M
Total Equity $192.0M $219.3M $246.5M $284.3M $193.9M $206.4M $192.0M $204.1M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$82.13M -$49.77M -$124.7M -$101.1M -$70.76M -$68.37M
Depreciation & Amortization $287K $58K $15K $2.35M $734K $121K
Stock-Based Compensation $12.55M $6.37M $1.34M $13.53M $7.87M $177K
Change in Receivables -$329K $0 -- -- -- --
Change in Inventory -$4.28M $0 -- -- -- --
Change in Payables -$90K -$4.28M $856K $194K $1.82M $594K
Operating Cash Flow -$69.17M -$59.39M -$60.38M -$87.98M -$52.85M -$8.72M
Capital Expenditure -$827K -$468K -$30K -$6.59M -$5.74M -$1.54M
Free Cash Flow -$70.00M -$59.86M -$60.41M -$94.57M -$58.59M -$10.27M
Purchases of Investments -$280.8M -$241.9M -$52.09M -$405.5M $0 --
Investing Cash Flow -$75.67M -$154.5M -$29.62M -$241.9M -$5.74M -$1.54M
Common Stock Issued -- $79.51M $0 -- -- --
Financing Cash Flow $149.7M $199.0M $80.70M $597K $417.5M $30.08M
Net Change in Cash $4.91M -$14.87M -$9.30M -$329.2M $358.9M $19.81M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$30.97M -$31.92M -$41.49M -$35.90M -$16.70M -$14.91M -$14.62M -$12.65M
Depreciation & Amortization $109K $110K $111K $107K $125K $19K $36K $25K
Stock-Based Compensation $4.13M $4.47M $4.32M $3.68M $3.47M $2.85M $2.56M $1.63M
Change in Receivables -$471K -$99K -$14K -$329K $0 $0 $0 --
Change in Inventory -$781K $19K -$889K -$3.33M -$949K $0 $0 --
Change in Payables -$1.13M -$4.28M $6.76M -$156K $1.69M -$857K -$771K $1.32M
Operating Cash Flow -$22.31M -$38.71M -$33.58M -$33.02M -$8.59M -$11.51M -$16.05M -$9.08M
Capital Expenditure $0 -$16K -$18K -$38K -$439K -$240K -$110K -$149K
Free Cash Flow -$22.31M -$38.73M -$33.60M -$33.06M -$9.03M -$11.75M -$16.16M -$9.23M
Purchases of Investments -$9.10M -$7.37M -$16.06M -$133.1M -$56.31M -$58.29M -$33.09M -$46.61M
Investing Cash Flow $28.66M $37.75M $33.16M -$89.81M -$4.33M -$414K $18.89M -$11.86M
Common Stock Issued -- -- -- -- -- -- $0 -$85K
Financing Cash Flow $0 $395K $14K $122.6M $598K $26.49M $44K $53K
Net Change in Cash $6.34M -$564K -$407K -$220K -$12.32M $14.57M $2.88M -$20.89M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 97.8% -- -- -- -- --
Operating Margin -477.5% -- -- -- -- --
Net Profit Margin -430.3% -- -- -- -- --
Return on Equity (ROE) -28.9% -24.4% -- -- -18.4% --
Return on Assets (ROA) -26.8% -23.1% -99.4% -31.4% -17.6% -303.0%
Current Ratio 14.23x 20.36x 3.63x 21.11x 31.44x 0.66x
Quick Ratio 14.09x 20.36x 9.95x 21.74x 31.04x 0.62x
Debt to Equity 0.00x 0.01x -- -- 0.03x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 82.0% 91.7% 92.9% 97.8% -- -- -- --
Operating Margin -1211.2% -631.7% -563.8% -477.5% -- -- -- --
Net Profit Margin -1135.0% -586.7% -519.3% -430.3% -- -- -- --
Return on Equity (ROE) -73.1% -57.5% -44.2% -28.9% -30.4% -25.4% -24.9% -24.4%
Return on Assets (ROA) -66.9% -53.3% -40.0% -26.8% -27.9% -24.1% -23.7% -23.1%
Current Ratio 11.66x 13.55x 10.40x 14.23x 12.69x 20.54x 23.09x 20.36x
Quick Ratio 11.39x 13.31x 10.26x 14.09x 12.63x 20.16x 22.65x 20.36x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.01x 0.01x 0.01x
Revenue Growth (YoY) -72.9% +9.7% -- -- -- -- -- --
Gross Profit Growth (YoY) -76.6% +4.1% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001815776) · from June 30, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:47 UTC · Open in terminal